Scientific Reports (May 2017)

Novel Locally Active Estrogens Accelerate Cutaneous Wound Healing-Part 2

  • Mario Brufani,
  • Nicoletta Rizzi,
  • Clara Meda,
  • Luigi Filocamo,
  • Francesca Ceccacci,
  • Virginia D’Aiuto,
  • Gabriele Bartoli,
  • Angela La Bella,
  • Luisa M. Migneco,
  • Rinaldo Marini Bettolo,
  • Francesca Leonelli,
  • Paolo Ciana,
  • Adriana Maggi

DOI
https://doi.org/10.1038/s41598-017-02820-y
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Estrogen deprivation is associated with delayed healing, while estrogen replacement therapy (ERT) accelerates acute wound healing and protects against development of chronic wounds. However, current estrogenic molecules have undesired systemic effects, thus the aim of our studies is to generate new molecules for topic administration that are devoid of systemic effects. Following a preliminary study, the new 17β-estradiol derivatives 1 were synthesized. The estrogenic activity of these novel compounds was evaluated in vitro using the cell line ERE-Luc B17 stably transfected with an ERE-Luc reporter. Among the 17β-estradiol derivatives synthesized, compounds 1e and 1f showed the highest transactivation potency and were therefore selected for the study of their systemic estrogenic activity. The study of these compounds in the ERE-Luc mouse model demonstrated that both compounds lack systemic effects when administered in the wound area. Furthermore, wound-healing experiments showed that 1e displays a significant regenerative and anti-inflammatory activity. It is therefore confirmed that this class of compounds are suitable for topical administration and have a clear beneficial effect on wound healing.